Investment firm Gilde Healthcare has closed its latest fund, which features Royal Philips as cornerstone investor and Johnson & Johnson as a limited partner.

Imperial Innovations furthers its commitment to Featurespace, a behavioural analytics spinout of Cambridge, by investing in the company for the third time.

Imperial Innovations exits its investment in Imperial College London spinout Alkion Biopharma, selling its shares to chemical company Evonik Industries.

The reinsurance firm has taken part in a $23.6m round for fintech company builder FinLeap that was closed at a $136m post-money valuation.

Cambridge Enterprise comes out on top for money returned on investments with impressive numbers across the board.

Imperial Innovations reinvests in Imperial College London spinout Inflowmatix in a $4.3m series A round that also gained investment from Parkwalk Advisors.

Drug developer Ergomed acquires Leicester spinout Haemostatix, which is developing a blood clotting peptide sequence, for $11.5m upfront and a potential future payment of $29m.

Two Portuguese corporates, Caixa and Sonae, have joined forces to support the retail analytics startup

Biovotion has secured a first close for its series A round, backed by Swiss Re and STMicroelectronics.